Sunil Agarwal
Director/Board Member chez ARVINAS, INC.
Profil
Sunil Agarwal est membre du conseil d'administration de Calithera Biosciences, Inc. et de Nesos, Inc. et directeur médical, vice-président exécutif et chef du développement chez Sana Biotechnology, Inc. Dans le cadre de sa carrière antérieure, il a été directeur médical et vice-président exécutif chez Ultragenyx Pharmaceutical, Inc, partenaire chez Sofinnova Investments, Inc, directeur chez Guilford Co, président de la recherche et du développement chez Juno Therapeutics, Inc, premier vice-président et chef mondial du développement clinique chez Genentech, Inc, directeur chez MedImmune LLC, directeur chez Kosan Biosciences, Inc et professeur adjoint de clinique à la GW School of Business. Il a obtenu un diplôme de premier cycle à l'université Cornell et un doctorat à la faculté de médecine de l'université Tufts.
Postes actifs de Sunil Agarwal
| Sociétés | Poste | Début |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 29/09/2015 |
| ARVINAS, INC. | Director/Board Member | 15/06/2023 |
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 08/04/2024 |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Director/Board Member | 18/04/2023 |
Nesos, Inc.
 Nesos, Inc. Medical SpecialtiesHealth Technology Nesos, Inc. develops wearable ear buds and software solutions for noninvasive pain therapy. The company is based in Redwood City, CA. The company was founded by Konstantinos Alataris. | Director/Board Member | - |
Anciens postes connus de Sunil Agarwal
| Sociétés | Poste | Fin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 10/04/2023 |
| MYOKARDIA, INC. | Director/Board Member | 17/11/2020 |
| JUNO THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/04/2017 |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Sunil Agarwal
| Cornell University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| ARVINAS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
| Guilford Co. | |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Nesos, Inc.
Nesos, Inc. Medical SpecialtiesHealth Technology Nesos, Inc. develops wearable ear buds and software solutions for noninvasive pain therapy. The company is based in Redwood City, CA. The company was founded by Konstantinos Alataris. | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Health Technology |
